Published in Malar J on September 15, 2008
Use of RDTs to improve malaria diagnosis and fever case management at primary health care facilities in Uganda. Malar J (2010) 2.86
Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries. Cochrane Database Syst Rev (2014) 1.71
Cost-effectiveness of malaria microscopy and rapid diagnostic tests versus presumptive diagnosis: implications for malaria control in Uganda. Malar J (2011) 1.70
Use and limitations of malaria rapid diagnostic testing by community health workers in war-torn Democratic Republic of Congo. Malar J (2009) 1.62
Accuracy of malaria rapid diagnostic tests in community studies and their impact on treatment of malaria in an area with declining malaria burden in north-eastern Tanzania. Malar J (2011) 1.59
Cost savings with rapid diagnostic tests for malaria in low-transmission areas: evidence from Dar es Salaam, Tanzania. Am J Trop Med Hyg (2010) 1.46
Cost implications of improving malaria diagnosis: findings from north-eastern Tanzania. PLoS One (2010) 1.46
From fever to anti-malarial: the treatment-seeking process in rural Senegal. Malar J (2010) 1.31
Use of HRP-2-based rapid diagnostic test for Plasmodium falciparum malaria: assessing accuracy and cost-effectiveness in the villages of Dielmo and Ndiop, Senegal. Malar J (2010) 1.31
Rapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settings. Cochrane Database Syst Rev (2014) 1.31
Effectiveness of combined intermittent preventive treatment for children and timely home treatment for malaria control. Malar J (2009) 1.24
Cost-effectiveness analysis of introducing RDTs for malaria diagnosis as compared to microscopy and presumptive diagnosis in central and peripheral public health facilities in Ghana. Am J Trop Med Hyg (2013) 1.19
Exploring provider and community responses to the new malaria diagnostic and treatment regime in Solomon Islands. Malar J (2011) 1.07
Willingness to pay for rapid diagnostic tests for the diagnosis and treatment of malaria in southeast Nigeria: ex post and ex ante. Int J Equity Health (2010) 1.01
Community case management of malaria: exploring support, capacity and motivation of community medicine distributors in Uganda. Health Policy Plan (2014) 1.00
Cost-effectiveness of three malaria treatment strategies in rural Tigray, Ethiopia where both Plasmodium falciparum and Plasmodium vivax co-dominate. Cost Eff Resour Alloc (2011) 0.98
Cost-effectiveness of diagnostic for malaria in Extra-Amazon Region, Brazil. Malar J (2012) 0.96
Two-year evaluation of Intermittent Preventive Treatment for Children (IPTc) combined with timely home treatment for malaria control in Ghana. Malar J (2011) 0.95
The impact of rapid malaria diagnostic tests upon anti-malarial sales in community pharmacies in Gwagwalada, Nigeria. Malar J (2013) 0.93
Incorporating Demand and Supply Constraints into Economic Evaluations in Low-Income and Middle-Income Countries. Health Econ (2016) 0.87
Recombinant antibodies specific for the Plasmodium falciparum histidine-rich protein 2. MAbs (2010) 0.86
Accuracy of two malaria rapid diagnostic tests (RDTS) for initial diagnosis and treatment monitoring in a high transmission setting in Uganda. Am J Trop Med Hyg (2015) 0.86
Rapid diagnostic test supply chain and consumption study in Cabo Delgado, Mozambique: estimating stock shortages and identifying drivers of stock-outs. Malar J (2014) 0.82
Health Workers Adjustment for Elimination of Malaria in a Low Endemic Area. Int J Prev Med (2015) 0.75
Fermentation and downstream process for high yield production of Plasmodium falciparum recombinant HRP II protein and its application in diagnosis. J Ind Microbiol Biotechnol (2013) 0.75
Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev (2002) 13.92
Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med (2007) 13.43
Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. BMJ (2007) 10.03
Malaria misdiagnosis: effects on the poor and vulnerable. Lancet (2004) 9.15
Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med (2005) 8.36
Improved diagnostic testing and malaria treatment practices in Zambia. JAMA (2007) 7.15
Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet (2000) 7.06
Seven years of regional malaria control collaboration--Mozambique, South Africa, and Swaziland. Am J Trop Med Hyg (2007) 6.04
Historical review of malarial control in southern African with emphasis on the use of indoor residual house-spraying. Trop Med Int Health (2004) 5.38
Effect of community-wide use of insecticide-treated nets for 3-4 years on malarial morbidity in Tanzania. Trop Med Int Health (2002) 3.73
Rapid diagnostic testing for malaria. Trop Med Int Health (2003) 3.63
Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis (2002) 3.46
Paracheck-Pf accuracy and recently treated Plasmodium falciparum infections: is there a risk of over-diagnosis? Malar J (2007) 3.11
Evaluation of rapid diagnostic tests: malaria. Nat Rev Microbiol (2006) 3.09
Reduction of malaria during pregnancy by permethrin-treated bed nets in an area of intense perennial malaria transmission in western Kenya. Am J Trop Med Hyg (2003) 2.97
Validity, reliability and ease of use in the field of five rapid tests for the diagnosis of Plasmodium falciparum malaria in Uganda. Trans R Soc Trop Med Hyg (2002) 2.66
Factors influencing the effectiveness of malaria control in Bioko Island, equatorial Guinea. Am J Trop Med Hyg (2007) 2.59
Short communication: An assessment of the use of malaria rapid tests by village health volunteers in rural Laos. Trop Med Int Health (2004) 2.56
Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in an area of low transmission. Trans R Soc Trop Med Hyg (1998) 2.54
Operational response to malaria epidemics: are rapid diagnostic tests cost-effective? Trop Med Int Health (2006) 2.39
Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa. Trop Med Int Health (2004) 1.89
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic. Clin Infect Dis (2004) 1.85
Rapid diagnostic devices for malaria: field evaluation of a new prototype immunochromatographic assay for the detection of Plasmodium falciparum and non-falciparum Plasmodium. Am J Trop Med Hyg (2003) 1.57
Economic advantage of a community-based malaria management program in the Brazilian Amazon. Am J Trop Med Hyg (2001) 1.23
The detection and treatment of Plasmodium falciparum malaria: time for change. J Postgrad Med (2004) 1.20
Antimalarial treatment with artemisinin combination therapy in Africa. BMJ (2005) 1.15
WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet (2004) 9.27
The health and health system of South Africa: historical roots of current public health challenges. Lancet (2009) 7.76
Seven years of regional malaria control collaboration--Mozambique, South Africa, and Swaziland. Am J Trop Med Hyg (2007) 6.04
In vivo parasitological measures of artemisinin susceptibility. J Infect Dis (2010) 4.25
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med (2009) 3.38
Inequities in under-five child malnutrition in South Africa. Int J Equity Health (2003) 2.80
Inequities in access to health care in South Africa. J Public Health Policy (2011) 2.63
The World Bank: false financial and statistical accounts and medical malpractice in malaria treatment. Lancet (2006) 2.22
Exploring inequalities in access to and use of maternal health services in South Africa. BMC Health Serv Res (2012) 2.01
Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa. Trop Med Int Health (2004) 1.89
World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs. Malar J (2007) 1.56
Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study. Br J Clin Pharmacol (2007) 1.49
Who pays for health care in Ghana? Int J Equity Health (2011) 1.49
Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients. PLoS Med (2006) 1.42
Measuring resistance to malaria. S Afr Med J (2004) 1.41
Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers. Eur J Clin Pharmacol (2008) 1.39
A network to monitor antimalarial drug resistance: a plan for moving forward. Trends Parasitol (2007) 1.37
Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children. Antimicrob Agents Chemother (2005) 1.35
The rationale and plan for creating a World Antimalarial Resistance Network (WARN). Malar J (2007) 1.25
The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria. Eur J Clin Pharmacol (2006) 1.17
Antimalarial treatment with artemisinin combination therapy in Africa. BMJ (2005) 1.15
Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN). Malar J (2010) 1.11
Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa. Drug Saf (2007) 1.11
Household burden of malaria in South Africa and Mozambique: is there a catastrophic impact? Trop Med Int Health (2008) 1.09
Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out. PLoS One (2011) 1.04
Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozambique. Am J Trop Med Hyg (2010) 1.03
Differential effect of regional drug pressure on dihydrofolate reductase and dihydropteroate synthetase mutations in southern Mozambique. Am J Trop Med Hyg (2008) 1.03
Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria. Malar J (2014) 1.01
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data. BMC Med (2015) 0.99
Blood folate concentrations and in vivo sulfadoxine-pyrimethamine failure in Malawian children with uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg (2005) 0.98
From targeted exemptions to user fee abolition in health care: experience from rural Zambia. Soc Sci Med (2010) 0.95
Equity in self-reported adult illness and use of health service in South Africa: inter-temporal comparison. J Health Popul Nutr (2003) 0.90
How experiences become data: the process of eliciting adverse event, medical history and concomitant medication reports in antimalarial and antiretroviral interaction trials. BMC Med Res Methodol (2013) 0.90
Establishing pharmacovigilance programs in resource-limited settings: the example of treating malaria. Expert Rev Clin Pharmacol (2010) 0.88
Economic evaluation of task-shifting approaches to the dispensing of anti-retroviral therapy. Hum Resour Health (2012) 0.87
Exploring the seasonality of reported treated malaria cases in Mpumalanga, South Africa. PLoS One (2013) 0.85
Towards malaria elimination in Mpumalanga, South Africa: a population-level mathematical modelling approach. Malar J (2014) 0.83
Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics. Br J Clin Pharmacol (2012) 0.80
Nonlinear mixed effects modeling of gametocyte carriage in patients with uncomplicated malaria. Malar J (2010) 0.79
Effects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in Mali. Malar J (2011) 0.76
Comment on: Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. Trans R Soc Trop Med Hyg (2005) 0.75
Rolling back malaria in Africa. S Afr Med J (2007) 0.75
Whither health economics? Aust N Z J Public Health (2009) 0.75